LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
Steady: 0 in the last 7 days
Updated oct 17
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- FDA granted 510(k) clearance to Masimo for its AFib monitoring capability.Sub-event
FDA actions on July 31 include LabCorp drug involvement, Intuitive Surgical clearance, and Masimo monitoring tech.1 source
Keep exploring
The entities involved
-
FDA
- The FDA is currently reviewing Medtronic's submission for its MiniMed 780G system, specifically regarding its use for Type 2 diabetes and label expansion into Europe.
- The Dietary Supplement Health and Education Act established the regulatory framework, with FDA oversight affecting the supplement industry.
-
LabCorp
clinical laboratory company
-
Intuitive Surgical
American corporation
-
Masimo
American healthcare company
Nothing else this week.
Related events
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- BioTech generated encouraging early data for MASH and POTS, and expects an FDA decision regarding cemdisiran next month.
Coverage
Newest first; wire copies grouped- StockStory1 Healthcare Stock to Consider Right Now and 2 That Underwhelm From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the ros
- Unknown outlet